Xiaopeng Han

2.3k total citations · 1 hit paper
53 papers, 1.9k citations indexed

About

Xiaopeng Han is a scholar working on Biomaterials, Pharmaceutical Science and Oncology. According to data from OpenAlex, Xiaopeng Han has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomaterials, 11 papers in Pharmaceutical Science and 11 papers in Oncology. Recurrent topics in Xiaopeng Han's work include Nanoparticle-Based Drug Delivery (13 papers), Advanced Drug Delivery Systems (11 papers) and Nanoplatforms for cancer theranostics (10 papers). Xiaopeng Han is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Advanced Drug Delivery Systems (11 papers) and Nanoplatforms for cancer theranostics (10 papers). Xiaopeng Han collaborates with scholars based in China, United States and Finland. Xiaopeng Han's co-authors include Jin Sun, Zhonggui He, Lifang Yin, Chao Qin, Lei Yang, Lin Li, Cong Luo, Yuqian Du, Yongjun Wang and Wei He and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Xiaopeng Han

49 papers receiving 1.9k citations

Hit Papers

Revolutionizing cancer treatment: enhancing CAR-T cell th... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
    2024 46 citations Xiaopeng Han, Dawei Zhang et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopeng Han China 22 680 662 591 351 317 53 1.9k
Jianping Zhou China 29 801 1.2× 907 1.4× 674 1.1× 274 0.8× 211 0.7× 62 2.2k
Chaofeng Mu China 24 684 1.0× 929 1.4× 602 1.0× 288 0.8× 399 1.3× 53 2.0k
Yu Cai China 27 618 0.9× 877 1.3× 497 0.8× 234 0.7× 377 1.2× 76 2.5k
Hima Bindu Ruttala South Korea 25 886 1.3× 700 1.1× 702 1.2× 231 0.7× 164 0.5× 30 1.8k
Fanzhu Li China 24 509 0.7× 614 0.9× 525 0.9× 314 0.9× 163 0.5× 81 1.7k
Zhigui Su China 27 912 1.3× 1.0k 1.5× 858 1.5× 406 1.2× 205 0.6× 57 2.4k
Bijay Kumar Poudel South Korea 31 866 1.3× 658 1.0× 728 1.2× 618 1.8× 167 0.5× 56 2.2k
Xuenong Zhang China 29 679 1.0× 1.1k 1.6× 567 1.0× 177 0.5× 237 0.7× 69 2.0k
Faisal Raza China 27 818 1.2× 784 1.2× 851 1.4× 229 0.7× 124 0.4× 92 2.4k
Kang Choon Lee South Korea 31 925 1.4× 1.3k 1.9× 507 0.9× 557 1.6× 316 1.0× 55 2.7k

Countries citing papers authored by Xiaopeng Han

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Han more than expected).

Fields of papers citing papers by Xiaopeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Han. The network helps show where Xiaopeng Han may publish in the future.

Co-authorship network of co-authors of Xiaopeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopeng Han. A scholar is included among the top collaborators of Xiaopeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopeng Han. Xiaopeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yihao, et al.. (2025). Comparative metabolomic in-depth exploration of red raspberry: new insights into changes in phytochemicals between different breeds. Analytical Methods. 17(9). 2112–2124. 1 indexed citations
2.
3.
Li, Jiayin, Yazhou Wang, Hao Li, et al.. (2025). Self-amplifying tumor-targeting nanoreactor for enhanced Immuno-Ferroptosis therapy in triple-negative breast cancer. Chemical Engineering Journal. 527. 171277–171277.
4.
Fu, Xiying, et al.. (2025). GLX351322-Loaded Nanoparticles Alleviate Chronic Stress-Induced Depressive Behaviors Through Inhibition of Ferroptosis and Oxidative Stress. International Journal of Nanomedicine. Volume 20. 14033–14055.
5.
Liu, Lisha, Xiaopeng Han, Xiaofei Xin, et al.. (2024). Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors. Nanomedicine Nanotechnology Biology and Medicine. 58. 102743–102743. 4 indexed citations
6.
Han, Xiaopeng, et al.. (2024). Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology. Frontiers in Immunology. 15. 1354825–1354825. 46 indexed citations breakdown →
7.
Wang, Hairong, Yuan Liu, Jiawen Cui, et al.. (2023). Effects of Scutellaria strigillosa Hemsl. extract on HepG2 cell proliferation and apoptosis through binding to aspartate β-hydroxylase. Biochemical and Biophysical Research Communications. 668. 62–69. 3 indexed citations
8.
9.
Zhang, Kai, Jingjing Li, Xiaofei Xin, et al.. (2021). Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer. Pharmaceutics. 13(12). 1990–1990. 15 indexed citations
10.
Li, Jingjing, Kai Zhang, Di Wu, et al.. (2021). Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19. Asian Journal of Pharmaceutical Sciences. 16(6). 772–783. 37 indexed citations
11.
Yu, Jianping, et al.. (2020). MiR-129-5p Restrains Apatinib Resistance in Human Gastric Cancer Cells Via Downregulating HOXC10. Cancer Biotherapy and Radiopharmaceuticals. 36(1). 95–105. 7 indexed citations
12.
Xu, Siyuan, Xiaopeng Han, Wei Wang, et al.. (2019). Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs. AAPS PharmSciTech. 20(2). 86–86. 5 indexed citations
13.
Teng, Chao, Zhongyue Yuan, Chenshi Lin, et al.. (2019). Desirable PEGylation for improving tumor selectivity of hyaluronic acid-based nanoparticles via low hepatic captured, long circulation times and CD44 receptor-mediated tumor targeting. Nanomedicine Nanotechnology Biology and Medicine. 24. 102105–102105. 21 indexed citations
14.
15.
Han, Xiaopeng, Jin Sun, Yongjun Wang, & Zhonggui He. (2015). PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution. Current Drug Metabolism. 16(1). 71–83. 16 indexed citations
16.
Lian, He, Tianhong Zhang, Jin Sun, et al.. (2013). Enhanced Oral Delivery of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based on a Mucus Bioadhesion and Penetration Mechanism. Molecular Pharmaceutics. 10(9). 3447–3458. 73 indexed citations
17.
Han, Xiaopeng, Hong-Tao Li, Lin Su, et al.. (2013). Effect of celecoxib plus standard chemotherapy on serum levels of vascular endothelial growth factor and cyclooxygenase-2 in patients with gastric cancer. Biomedical Reports. 2(2). 183–187. 15 indexed citations
18.
Zhang, Youxi, Jin Sun, Yikun Gao, et al.. (2013). An HPLC–MS/MS method for simultaneous determination of decitabine and its valyl prodrug valdecitabine in rat plasma. Journal of Chromatography B. 917-918. 78–83. 8 indexed citations
19.
Fu, Qiang, Jin Sun, Xiaoyu Ai, et al.. (2013). Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. International Journal of Pharmaceutics. 448(1). 290–297. 78 indexed citations
20.
Sun, Jin, et al.. (2011). Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Development and Industrial Pharmacy. 37(6). 727–736. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Chaofeng Mu Breakdown of academic impact, for papers by Yu Cai Breakdown of academic impact, for papers by Hima Bindu Ruttala Breakdown of academic impact, for papers by Fanzhu Li Breakdown of academic impact, for papers by Zhigui Su Breakdown of academic impact, for papers by Bijay Kumar Poudel Breakdown of academic impact, for papers by Xuenong Zhang Breakdown of academic impact, for papers by Faisal Raza Breakdown of academic impact, for papers by Kang Choon Lee
Rankless by CCL
2026